{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T07:04:25.897197",
  "count": 43,
  "transactions": [
    {
      "id": 14702,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2024-03-13",
      "transaction_shares": "20000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "68306"
    },
    {
      "id": 14691,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-03-01",
      "transaction_shares": "358",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "13431"
    },
    {
      "id": 14698,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-01",
      "transaction_shares": "1",
      "transaction_price": "967.5",
      "transaction_type": "S",
      "shares_after_transaction": "18381"
    },
    {
      "id": 14681,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1020",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "50999"
    },
    {
      "id": 14682,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "854",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2236"
    },
    {
      "id": 14683,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-26",
      "transaction_shares": "1000",
      "transaction_price": "990.0",
      "transaction_type": "S",
      "shares_after_transaction": "36543"
    },
    {
      "id": 14688,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-26",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14686,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "27349"
    },
    {
      "id": 14690,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1000",
      "transaction_price": "967.65",
      "transaction_type": "S",
      "shares_after_transaction": "37543"
    },
    {
      "id": 4668,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 14693,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "172723",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "925209"
    },
    {
      "id": 4666,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 14689,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-14",
      "transaction_shares": "439",
      "transaction_price": "937.94",
      "transaction_type": "S",
      "shares_after_transaction": "30373"
    },
    {
      "id": 4671,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 4675,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 14696,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2024-02-09",
      "transaction_shares": "12250",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "32628"
    },
    {
      "id": 14701,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Finance & CFO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "344",
      "transaction_price": "950.49",
      "transaction_type": "S",
      "shares_after_transaction": "18947"
    },
    {
      "id": 4676,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 14703,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "500",
      "transaction_price": "413.33",
      "transaction_type": "M",
      "shares_after_transaction": "26849"
    },
    {
      "id": 4670,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 4677,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 14695,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-02-07",
      "transaction_shares": "1000",
      "transaction_price": "950.0",
      "transaction_type": "S",
      "shares_after_transaction": "38543"
    },
    {
      "id": 14704,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-07",
      "transaction_shares": "100",
      "transaction_price": "947.34",
      "transaction_type": "S",
      "shares_after_transaction": "59956"
    },
    {
      "id": 4662,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 14680,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-05",
      "transaction_shares": "1000",
      "transaction_price": "934.71",
      "transaction_type": "S",
      "shares_after_transaction": "13789"
    },
    {
      "id": 4664,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 4669,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 14685,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2024-02-02",
      "transaction_shares": "30750",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "82769"
    },
    {
      "id": 14694,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-02-02",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23974"
    },
    {
      "id": 4661,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 4663,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 14679,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "1",
      "transaction_price": "939.53",
      "transaction_type": "S",
      "shares_after_transaction": "18481"
    },
    {
      "id": 14684,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-02-01",
      "transaction_shares": "273",
      "transaction_price": "945.61",
      "transaction_type": "S",
      "shares_after_transaction": "14789"
    },
    {
      "id": 4674,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 14700,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "400",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23856"
    },
    {
      "id": 4667,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 14692,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-30",
      "transaction_shares": "827",
      "transaction_price": "380.95",
      "transaction_type": "M",
      "shares_after_transaction": "2209"
    },
    {
      "id": 4665,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 4672,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 4673,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    },
    {
      "id": 14687,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-23",
      "transaction_shares": "2707",
      "transaction_price": "625.6",
      "transaction_type": "M",
      "shares_after_transaction": "9089"
    },
    {
      "id": 14697,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-23",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "21860"
    },
    {
      "id": 14699,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-23",
      "transaction_shares": "1100",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "24084"
    }
  ]
}